Australians Denied the latest Anticoagulants by penny-pinching Government – would rather we used Warfarin (rat poison)…
My View The government is denying 200,000 people the safety of a new anti-coagulant – because it will cost $1 …
Tag Archives: Dabigatran
New Bristol, Pfizer clot drug saves lives in study
New Bristol, Pfizer clot drug saves lives in study By Ben Hirschler (Reuters) PARIS | Sun Aug 28, 2011 8:46am …
Xarelto Joins the Rush to Novel New Anticoagulants
Xarelto Joins the Rush to Novel New Anticoagulants August 26, 2011 Dr. Pullen The recent FDA approval of Xarelto (generic …
New Anticoagulants – 5 Deaths Prompt Dabigatran Safety Advisory in Japan
Deaths Prompt Dabigatran Safety Advisory in Japan Shelley Wood Source Medscape August 17, 2011 (Tokyo, Japan) — The Japanese Ministry …
Pradaxa Review
Pradaxa Review Source: Blood Thinners Org Overall Grade: B+ Rating: Good Safety: Good Efficacy: Excellent Pradaxa, developed by the pharmaceutical …
Time to revisit dabigatran dose in the US?
Time to revisit dabigatran dose in the US? May 31, 2011 | Megan Brooks Source: the Heart org Adapted from …
New Anti-Coagulants are Good BUT Caution Needed With Dabigatran in the Elderly
From Heartwire Caution Needed With Dabigatran in the Elderly Lisa Nainggolan August 4, 2011 (Paris, France) — New reports of …
New oral anticoagulant drugs – mechanisms of action
Experimental and clinical pharmacology New oral anticoagulant drugs – mechanisms of action Timothy Brighton, Haematologist, South Eastern Area Laboratory Service …
Anti-coagulant Blockbuster Drugs Are Here…
Anti-coagulant Blockbuster Drugs Are Here Source: Click here July 24, 2011 About the author: Smith On Stocks My name is Larry Smith. …
New Oral Anti-Coagulants get the Thumbs Up
The new oral anticoagulants, do they change the benefit vs. risk for thromboprophylaxis in association to ambulatory surgery? Squizzato A, …
Is Warfarin a Drug of the Past – I hope so…
My View This looks like good news – I found Warfarin dreadful to be on for 3 months… FDA Approves …
Earl's View 